Cyabra, Inc. (CYAB) CTO buys shares and Series A/B warrants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cyabra, Inc. Chief Technology Officer Shraga Ido purchased 53,650 shares of common stock from the company in a private placement at $0.435 per share, bringing his direct holdings to 894,199 shares.
He also acquired Series A and Series B warrants, each to purchase up to 53,650 common shares, with exercise prices of $0.45 and $0.50 per share. These warrants become exercisable only after requisite stockholder approval; the Series B warrants expire 12 months and the Series A warrants five years after their initial exercise dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 107,300 shares ($50,968)
Net Buy
3 txns
Insider
Shraga Ido
Role
Chief Technology Officer
Bought
107,300 shs ($51K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock Warrants (right to buy) | 53,650 | $0.45 | $24K |
| Purchase | Common Stock Warrants (right to buy) | 53,650 | $0.50 | $27K |
| Grant/Award | Common Stock | 53,650 | $0.00 | -- |
Holdings After Transaction:
Common Stock Warrants (right to buy) — 53,650 shares (Direct);
Common Stock — 894,199 shares (Direct)
Footnotes (1)
- On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share. The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement. The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval. The Series B Warrants expire on the date that is twelve (12) months following the initial exercise date. The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement. The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval. The Series A Warrants expire five (5) years following the initial exercise date.
Key Figures
Common shares purchased: 53,650 shares
Purchase price per share: $0.435
Direct common shares after transaction: 894,199 shares
+5 more
8 metrics
Common shares purchased
53,650 shares
Purchased from Cyabra in a private placement on July 10, 2026 at $0.435 per share
Purchase price per share
$0.435
Price paid for each common share in the private placement
Direct common shares after transaction
894,199 shares
Direct holdings of Cyabra common stock following the July 10, 2026 purchase
Series A Warrants underlying shares
53,650 shares
Number of common shares purchasable under the Series A Warrants acquired
Series A exercise price
$0.45 per share
Exercise price of the Series A Warrants for Cyabra common stock
Series B Warrants underlying shares
53,650 shares
Number of common shares purchasable under the Series B Warrants acquired
Series B exercise price
$0.50 per share
Exercise price of the Series B Warrants for Cyabra common stock
Series B warrant term
12 months
Series B Warrants expire 12 months after their initial exercise date
Key Terms
Private Placement, Series B Warrants, Series A Warrants, requisite stockholder approval, +1 more
5 terms
Private Placement financial
"purchased 53,650 shares of common stock ... in a private placement transaction"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Series B Warrants financial
"purchased Series B warrants to purchase up to 53,650 shares of Common Stock"
Series B warrants are contracts issued alongside a company's Series B financing that give the holder the right to buy a set number of shares at a fixed price within a specified time. For investors, they matter because they can provide leveraged upside if the company grows, or they can dilute existing shareholders when exercised—like a coupon promising a future share at a known price that can add value or change ownership stakes.
Series A Warrants financial
"purchased Series A warrants to purchase up to 53,650 shares of Common Stock"
Series A warrants are financial tools that give the holder the right to buy shares of a company at a specific price within a certain period. They are often issued alongside investments to provide additional potential profit if the company's value increases. For investors, they can offer a chance to benefit from future growth without committing immediate capital to buying shares.
requisite stockholder approval regulatory
"will become exercisable upon the receipt of the requisite stockholder approval"
initial exercise date financial
"expire on the date that is twelve (12) months following the initial exercise date"
FAQ
What insider transaction did CYAB’s CTO report on July 10, 2026?
Cyabra’s CTO Shraga Ido bought 53,650 common shares at $0.435 per share in a private placement, raising his direct holdings to 894,199 shares. He also acquired Series A and Series B warrants, each allowing purchase of up to 53,650 additional common shares.
At what prices can the CYAB warrants be exercised by the CTO?
The warrants reported by CYAB’s CTO have exercise prices of $0.45 per share for the Series A Warrants and $0.50 per share for the Series B Warrants. Each series relates to 53,650 underlying common shares, exercisable after stockholder approval.
When do the Series A and Series B CYAB warrants held by the CTO expire?
The Series B Warrants expire 12 months after their initial exercise date, while the Series A Warrants expire five years after their initial exercise date. Both series become exercisable only after Cyabra obtains the requisite stockholder approval.